ClinicalTrials.gg
Not yet recruitingNCT06128811Updated Nov 13, 2023

Dental Isolation Systems Among Pediatric Patients With Different Airway Patency

An interventional study of Rubber Dam Isolation and DryShieled isolation in Airway Obstruction, Pain and Behavior, sponsored by King Abdulaziz University. Not yet recruiting at 1 site in Saudi Arabia. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-13.

Sponsored by King Abdulaziz University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This randomized clinical trial will aim to evaluate the effect of DryShield isolation (DSI) and Rubber Dam isolation (RDI) systems on arterial oxygen saturation (SpO2), heart rate (HR), blood pressure (BP), behavior, subjective pain and discomfort, and time required among children with different airway patency based on Modified Mallampati classification (MMC). Healthy, cooperative 6-12-year-old children who need fissure sealant in at least two contralateral fully erupted permanent first molars will be included. The airway patency will be determined using MMC by two trained and calibrated dentists. Participants will be categorized based on their MMC score into patent airway (MMC Class I and II) and non-patent airway (MMC Class III and IV). During the treatment, the dental procedure will be videotaped, and the vital signs, including SpO2, HR, and BP, will be recorded every three minutes. A Validated Arabic Version of the Wong-Baker Pain Rating and the Face, Legs, Activity, Cry, Consolability (FLACC) scales will be utilized to record the participants' pain levels. In contrast, Frankl's Behavior will record their behavior during the dental procedure. Following the dental treatment, the participants' subjective pain and discomfort will be evaluated using a previously validated Arabic interview questionnaire.

Read the detailed description

This study will aim to evaluate the effect of DryShield isolation system and rubber dam isolation on arterial oxygen saturation, heart rate, blood pressure, behavior, subjective pain and discomfort, and time required among 6-12-years-old healthy children with different airway patency based on Modified Mallampati classification scores.

This split-mouth randomized clinical trial will be conducted in the Pediatric Dentistry Department at King Abdulaziz University Dental Hospital Faculty of Dentistry (KAUDH) after obtaining ethical approval from the Research Ethics Committee at King Abdulaziz University.

Healthy, cooperative 6-12-year-old children who need fissure sealants in at least two contralateral fully erupted permanent first molars will be included. Children with partially erupted, previously restored, or carious first molars, children with uncooperative behavior during their previous dental treatment, children with fixed orthodontic appliances, and children with nasal obstruction will be excluded.

Children attending the pediatric dentistry clinics during the study period will be screened for eligibility. The parents or guardians of eligible children will be approached and given information about the study, including the risks, benefits, and drawbacks. If they agree to participate, an Arabic consent and assent form will be signed, and a treatment appointment will be scheduled. The airway patency assessment will be performed during the screening visit by two trained and calibrated dentists using Modified Mallampati classification scores. The participants will be asked to sit upright with their chin parallel to the floor, open their mouths to the maximum, and protrude their tongue without phonation to determine their Modified Mallampati classification score, ranging from one to four. Class I indicates that the soft palate, fauces, uvula, and tonsillar pillars are clearly visible. Class II means the soft palate, fauces, and the uvula are visible, while Class III is when only the soft palate and base of the uvula are visible. Finally, Class IV is when the soft palate is not visible. (13) Participants will be categorized based on their Modified Mallampati classification scores into two groups: patent airway (Class I and II) and non-patent airway (Class III and IV).

If a participant has more than two contralateral and fully erupted permanent first molars, only one pair of molars will be randomly selected to be included in the study.

At the scheduled appointment, the participants' age, sex, and previous experience with dental isolation will be recorded. Five minutes after the participant is seated on the dental chair, a pulse oximeter (OxyWatch, ChoiceMMed, Hamburg, Germany) will be placed on the right forefinger to record the SpO2 and HR as a baseline, and an automatic BP cuff will be applied to the left upper to record the baseline BP. The SpO2, HR, and BP will be recorded at three-minute intervals until the removal of the isolation system. Additionally, a stopwatch will measure the chair time required to complete the entire dental procedure. The time needed to assemble the RDI or the DSI will not be included. Also, only topical anesthesia will be applied before RD clamp application.

Both fissure sealants will be provided at the same appointment by the same trained and calibrated dentist. The Tell-Show-Do behavior management technique will be utilized with all participants. The dental procedure will be videotaped using a high-resolution camera fixed in the clinic. The recorded videos will be used to assess the participants' behavioral pain and discomfort using the Face, Legs, Activity, Cry, Consolability (FLACC) scale and behavior using Frankl behavior classification by two trained and calibrated evaluators independently.

For the DSI, a pedo-size mouthpiece will be utilized with all the participants. After proper isolation, fissure sealant (Conseal-F TM SDI) will be applied following the manufacturer's instructions.

After the fissure sealant procedure, the participants' subjective pain and discomfort will be evaluated using a validated Arabic Version of the Wong-Baker Pain Rating Scale and a previously validated Arabic interview questionnaire. The questionnaire will ask the participants to rate their experience on a numerical scale from zero to 10, with zero meaning "no irritating factor at all" and 10 indicating "presence of irritating factor all the time." The factors included noise, gagging sensation, fluid leak, stretching, pressure, pain, and discomfort associated with the isolation system.

02

Conditions studied

  • Airway Obstruction
  • Pain
  • Behavior
03

In context

Airway Obstruction

148 studies on the registry are indexed under Airway Obstruction; 26 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 93 interventional studies indexed under Airway Obstruction.

Browse Airway Obstruction studies →

Lead sponsor

King Abdulaziz University is the lead sponsor of 98 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy
  2. Cooperative
  3. 6-12-year-old children
  4. Who need fissure sealants in at least two contralateral fully erupted permanent first molar

Exclusion criteria

Exclusion Criteria:

  1. Children with partially erupted, previously restored, or carious first molars.
  2. Children with uncooperative behavior during their previous dental treatment.
  3. Children with fixed orthodontic appliances
  4. Children with nasal obstruction
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group 1

    Participants who will receive rubber dam isolation followed by DryShieled will be considered group 1.

    Device: Rubber Dam Isolation · Device: DryShieled isolation · Other: fissure sealant

  • Active comparator
    Group 2

    Participants who will receive DryShieled followed by rubber dam isolation will be considered group 2.

    Device: Rubber Dam Isolation · Device: DryShieled isolation · Other: fissure sealant

Interventions

  • DeviceRubber Dam Isolation

    Rubber dam isolation will be placed using a proper size dental clamp on the first permanent molar after topical anesthesia application.

  • DeviceDryShieled isolation

    For the DryShieled isolation, a pedo-size mouthpiece will be utilized with all the participants.

  • Otherfissure sealant

    After proper isolation, fissure sealant (Conseal-F TM SDI) will be applied following the manufacturer's instructions, and the quality of the applied fissure sealant will be checked with an explorer. An additional layer will be applied if any deficiency is detected

06

What researchers measure

Primary outcomes

  1. Arterial oxygen saturation

    Five minutes after the participant is seated on the dental chair, a pulse oximeter (OxyWatch, ChoiceMMed, Hamburg, Germany) will be placed on the right forefinger to record the arterial oxygen saturation.

    Time frame: Baseline before starting the dental procedure and then during the procedure at three-minute intervals until the removal of the isolation system.

  2. Behavior

    The dental procedure will be videotaped using a high-resolution camera fixed in the clinic. The recorded videos will be used to assess the participants's behavior using Frankl behavior classification by two trained and calibrated evaluators independently.

    Time frame: During the dental procedure.

  3. Subjective pain and discomfort

    The participants' subjective pain and discomfort will be evaluated using a validated Arabic Version of the Wong-Baker Pain Rating Scale and a previously validated Arabic interview questionnaire.

    Time frame: immediately after the end of the dental procedure.

  4. Time required in minutes

    A stopwatch will be used to measure the chair-time required to complete the entire dental procedure in minutes.

    Time frame: During the dental procedure.

  5. Heart rate per minute (beat per minute)

    Five minutes after the participant is seated on the dental chair, a pulse oximeter (OxyWatch, ChoiceMMed, Hamburg, Germany) will be placed on the right forefinger to record the heart rate per minute.

    Time frame: Baseline before starting the dental procedure and then during the procedure at three-minute intervals until the removal of the isolation system.

  6. Systolic and Diastolic blood pressure in millimeters of mercury (mmHg)

    Five minutes after the participant is seated on the dental chair, an automatic blood pressure cuff will be applied to the left upper to record the blood pressure in millimeters of mercury (mmHg).

    Time frame: Baseline before starting the dental procedure and then during the procedure at three-minute intervals until the removal of the isolation system.

  7. Behavioral pain and discomfort

    The dental procedure will be videotaped using a high-resolution camera fixed in the clinic. The recorded videos will be used to assess the participants' behavioral pain and discomfort using the Face, Legs, Activity, Cry, Consolability (FLACC) scale two trained and calibrated evaluators independently.

    Time frame: During the dental procedure

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2023; primary completion for Dec 2023, 1 month later.

Of 36 non-industry interventional studies with no phase under Airway Obstruction, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 37. This study's planned 1 month is below that.

Counting every sponsor, half of 44 studies reached it within 16 months; a quarter within 3 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 1, 2023
First posted
Nov 13, 2023
StartEst.
Nov 15, 2023
Primary completionEst.
Dec 30, 2023
CompletionEst.
Jan 30, 2024
Last update
Nov 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06128811
Lead sponsor
King Abdulaziz University
Responsible party
Sara M.Bagher (Associate Professor, King Abdulaziz University) — Principal investigator
First posted
Nov 13, 2023
Start date
Nov 15, 2023 (estimated)
Primary completion
Dec 30, 2023 (estimated)
Completion
Jan 30, 2024 (estimated)
Last update
Nov 13, 2023

Study contacts

Sara M Bagher, Master
Contact
sbagher@kau.edu.sa
00966547433525
Sara M Bagher, Mater
principal investigator · Associate Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion